APO Research

APO RESEARCH · REPORT

Dental Drug

There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations.

Product & engineering

Understand the product.

There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations.

Selected research

Market Analysis & Forecast

Global Dental Drug Market Analysis and Forecast 2026-2032

Market perspective

There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations.

Global Dental Drug key players include Merck, Bayer, JandJ, GSK, 3M, etc. Global top five players hold a share about 40%.

North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, having a total share about 55 percent.

Read the full market overview

In terms of product, OTC is the largest segment, with a share about 60%. And in terms of application, the largest application is Hospitals, followed by Dental Clinics, Drugstores.

Report Includes

This report presents an overview of global market for Dental Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dental Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Dental Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dental Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dental Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Dental Drug revenue, projected growth trends, production technology, application and end-user industry.

Dental Drug Segment by Company

Merck

Bayer

JandJ

GSK

3M

Sunstar

Colgate-Palmolive

DenMat

Showa Yakuhin Kako

Bausch Health

Septodont

Roche

PerioChip

Hutchison China MediTech

Xiuzheng Pharmaceutical

Acteon

Xttrium Laboratorie

Mediwin Pharmaceuticals

Dental Drug Segment by Type

OTC

Prescription Product

Dental Drug Segment by Application

Hospitals

Dental Clinics

Drugstores

Dental Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dental Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dental Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dental Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Dental Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Dental Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dental Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dental Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. OTC Major Player Table 3. Prescription Product Major Player Table 4. Global Dental Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Dental Clinics Major Player Table 7. Drugstores Major Player Table 8. Dental Drug Industry Trends Table 9. Dental Drug Industry Drivers Table 10. Dental Drug Industry Opportunities and Challenges Table 11. Dental Drug Industry Restraints Table 12. Global Dental Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Dental Drug Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Dental Drug Market Share by Region (2021-2026) Table 15. Global Dental Drug Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Dental Drug Market Share by Region (2027-2032) Table 17. Global Dental Drug Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Dental Drug Revenue Market Share by Players (2021-2026) Table 19. Global Dental Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Dental Drug Key Players Headquarters & Area Served Table 21. Global Dental Drug Players, Product Type & Application Table 22. Global Dental Drug Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Dental Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Dental Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Dental Drug Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Dental Drug Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Dental Drug Revenue Market Share by Type (2021-2026) Table 29. Global Dental Drug Revenue Market Share by Type (2027-2032) Table 30. Global Dental Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Dental Drug Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Dental Drug Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Dental Drug Revenue Market Share by Application (2021-2026) Table 34. Global Dental Drug Revenue Market Share by Application (2027-2032) Table 35. Merck Company Information Table 36. Merck Business Overview Table 37. Merck Dental Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Merck Dental Drug Product Portfolio Table 39. Merck Recent Development Table 40. Bayer Company Information Table 41. Bayer Business Overview Table 42. Bayer Dental Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Bayer Dental Drug Product Portfolio Table 44. Bayer Recent Development Table 45. JandJ Company Information Table 46. JandJ Business Overview Table 47. JandJ Dental Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. JandJ Dental Drug Product Portfolio Table 49. JandJ Recent Development Table 50. GSK Company Information Table 51. GSK Business Overview Table 52. GSK Dental Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. GSK Dental Drug Product Portfolio Table 54. GSK Recent Development Table 55. 3M Company Information Table 56. 3M Business Overview Table 57. 3M Dental Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. 3M Dental Drug Product Portfolio Table 59. 3M Recent Development Table 60. Sunstar Company Information Table 61. Sunstar Business Overview Table 62. Sunstar Dental Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Sunstar Dental Drug Product Portfolio Table 64. Sunstar Recent Development Table 65. Colgate-Palmolive Company Information Table 66. Colgate-Palmolive Business Overview Table 67. Colgate-Palmolive Dental Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Colgate-Palmolive Dental Drug Product Portfolio Table 69. Colgate-Palmolive Recent Development Table 70. DenMat Company Information Table 71. DenMat Business Overview Table 72. DenMat Dental Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. DenMat Dental Drug Product Portfolio Table 74. DenMat Recent Development Table 75. Showa Yakuhin Kako Company Information Table 76. Showa Yakuhin Kako Business Overview Table 77. Showa Yakuhin Kako Dental Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Showa Yakuhin Kako Dental Drug Product Portfolio Table 79. Showa Yakuhin Kako Recent Development Table 80. Bausch Health Company Information Table 81. Bausch Health Business Overview Table 82. Bausch Health Dental Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Bausch Health Dental Drug Product Portfolio Table 84. Bausch Health Recent Development Table 85. Septodont Company Information Table 86. Septodont Business Overview Table 87. Septodont Dental Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 88. Septodont Dental Drug Product Portfolio Table 89. Septodont Recent Development Table 90. Roche Company Information Table 91. Roche Business Overview Table 92. Roche Dental Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 93. Roche Dental Drug Product Portfolio Table 94. Roche Recent Development Table 95. PerioChip Company Information Table 96. PerioChip Business Overview Table 97. PerioChip Dental Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 98. PerioChip Dental Drug Product Portfolio Table 99. PerioChip Recent Development Table 100. Hutchison China MediTech Company Information Table 101. Hutchison China MediTech Business Overview Table 102. Hutchison China MediTech Dental Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 103. Hutchison China MediTech Dental Drug Product Portfolio Table 104. Hutchison China MediTech Recent Development Table 105. Xiuzheng Pharmaceutical Company Information Table 106. Xiuzheng Pharmaceutical Business Overview Table 107. Xiuzheng Pharmaceutical Dental Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 108. Xiuzheng Pharmaceutical Dental Drug Product Portfolio Table 109. Xiuzheng Pharmaceutical Recent Development Table 110. Acteon Company Information Table 111. Acteon Business Overview Table 112. Acteon Dental Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 113. Acteon Dental Drug Product Portfolio Table 114. Acteon Recent Development Table 115. Xttrium Laboratorie Company Information Table 116. Xttrium Laboratorie Business Overview Table 117. Xttrium Laboratorie Dental Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 118. Xttrium Laboratorie Dental Drug Product Portfolio Table 119. Xttrium Laboratorie Recent Development Table 120. Mediwin Pharmaceuticals Company Information Table 121. Mediwin Pharmaceuticals Business Overview Table 122. Mediwin Pharmaceuticals Dental Drug Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 123. Mediwin Pharmaceuticals Dental Drug Product Portfolio Table 124. Mediwin Pharmaceuticals Recent Development Table 125. North America Dental Drug Revenue by Type (2021-2026) & (US$ Million) Table 126. North America Dental Drug Revenue by Type (2027-2032) & (US$ Million) Table 127. North America Dental Drug Revenue by Application (2021-2026) & (US$ Million) Table 128. North America Dental Drug Revenue by Application (2027-2032) & (US$ Million) Table 129. North America Dental Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Dental Drug Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Dental Drug Revenue by Country (US$ Million) & (2027-2032) Table 132. Europe Dental Drug Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe Dental Drug Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe Dental Drug Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Dental Drug Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Dental Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Dental Drug Revenue by Country (2021-2026) & (US$ Million) Table 138. Europe Dental Drug Revenue by Country (US$ Million) & (2027-2032) Table 139. China Dental Drug Revenue by Type (2021-2026) & (US$ Million) Table 140. China Dental Drug Revenue by Type (2027-2032) & (US$ Million) Table 141. China Dental Drug Revenue by Application (2021-2026) & (US$ Million) Table 142. China Dental Drug Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Dental Drug Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia Dental Drug Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia Dental Drug Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Dental Drug Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Dental Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Dental Drug Revenue by Region (US$ Million) & (2021-2026) Table 149. Asia Dental Drug Revenue by Region (US$ Million) & (2027-2032) Table 150. SAMEA Dental Drug Revenue by Type (2021-2026) & (US$ Million) Table 151. SAMEA Dental Drug Revenue by Type (2027-2032) & (US$ Million) Table 152. SAMEA Dental Drug Revenue by Application (2021-2026) & (US$ Million) Table 153. SAMEA Dental Drug Revenue by Application (2027-2032) & (US$ Million) Table 154. SAMEA Dental Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. SAMEA Dental Drug Revenue by Country (2021-2026) & (US$ Million) Table 156. SAMEA Dental Drug Revenue by Country (US$ Million) & (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Dental Drug Image Figure 2. Global Dental Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dental Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. OTC Image Figure 5. Prescription Product Image Figure 6. Global Dental Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dental Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Dental Clinics Image Figure 10. Drugstores Image Figure 11. Global Dental Drug Market Size (US$ Million) & (2021-2032) Figure 12. Global Dental Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Dental Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Dental Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Dental Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Dental Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Dental Drug Revenue Market Share by Type (2021-2032) Figure 19. Global Dental Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Dental Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Dental Drug Revenue Market Share by Application (2021-2032) Figure 22. North America Dental Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Dental Drug Revenue Share by Type (2021-2032) Figure 24. North America Dental Drug Revenue Share by Application (2021-2032) Figure 25. North America Dental Drug Revenue Share by Country (2021-2032) Figure 26. United States Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Dental Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Dental Drug Revenue Share by Type (2021-2032) Figure 31. Europe Dental Drug Revenue Share by Application (2021-2032) Figure 32. Europe Dental Drug Revenue Share by Country (2021-2032) Figure 33. Germany Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Dental Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Dental Drug Revenue Share by Type (2021-2032) Figure 43. China Dental Drug Revenue Share by Application (2021-2032) Figure 44. Asia Dental Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Dental Drug Revenue Share by Type (2021-2032) Figure 46. Asia Dental Drug Revenue Share by Application (2021-2032) Figure 47. Asia Dental Drug Revenue Share by Region (2021-2032) Figure 48. Japan Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Dental Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Dental Drug Revenue Share by Type (2021-2032) Figure 56. SAMEA Dental Drug Revenue Share by Application (2021-2032) Figure 57. SAMEA Dental Drug Revenue Share by Country (2021-2032) Figure 58. Brazil Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Dental Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • OTC
  • Prescription Product
Applications
  • Hospitals
  • Dental Clinics
  • Drugstores
Companies covered
  • Merck
  • Bayer
  • JandJ
  • GSK
  • 3M
  • Sunstar
  • Colgate-Palmolive
  • DenMat
  • Showa Yakuhin Kako
  • Bausch Health
  • Septodont
  • Roche
  • PerioChip
  • Hutchison China MediTech
  • Xiuzheng Pharmaceutical
  • Acteon
  • Xttrium Laboratorie
  • Mediwin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dental Drug Market by Type
  3. 1.2.1 Global Dental Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 OTC
  5. 1.2.3 Prescription Product
  6. 1.3 Dental Drug Market by Application
  7. 1.3.1 Global Dental Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Dental Clinics
  10. 1.3.4 Drugstores
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Dental Drug Market Dynamics
  1. 2.1 Dental Drug Industry Trends
  2. 2.2 Dental Drug Industry Drivers
  3. 2.3 Dental Drug Industry Opportunities and Challenges
  4. 2.4 Dental Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Dental Drug Market Perspective (2021-2032)
  2. 3.2 Global Dental Drug Growth Trends by Region
  3. 3.2.1 Global Dental Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dental Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Dental Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Dental Drug Revenue by Players
  2. 4.1.1 Global Dental Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Dental Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Dental Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dental Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Dental Drug Key Players Headquarters & Area Served
  7. 4.4 Global Dental Drug Players, Product Type & Application
  8. 4.5 Global Dental Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Dental Drug Market CR5 and HHI
  11. 4.6.3 2025 Dental Drug Tier 1, Tier 2, and Tier 3
5 Dental Drug Market Size by Type
  1. 5.1 Global Dental Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Dental Drug Revenue by Type (2021-2032)
  3. 5.3 Global Dental Drug Revenue Market Share by Type (2021-2032)
6 Dental Drug Market Size by Application
  1. 6.1 Global Dental Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Dental Drug Revenue by Application (2021-2032)
  3. 6.3 Global Dental Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Dental Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck Dental Drug Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer Dental Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Dental Drug Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 JandJ
  14. 7.3.1 JandJ Company Information
  15. 7.3.2 JandJ Business Overview
  16. 7.3.3 JandJ Dental Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 JandJ Dental Drug Product Portfolio
  18. 7.3.5 JandJ Recent Developments
  19. 7.4 GSK
  20. 7.4.1 GSK Company Information
  21. 7.4.2 GSK Business Overview
  22. 7.4.3 GSK Dental Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 GSK Dental Drug Product Portfolio
  24. 7.4.5 GSK Recent Developments
  25. 7.5 3M
  26. 7.5.1 3M Company Information
  27. 7.5.2 3M Business Overview
  28. 7.5.3 3M Dental Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 3M Dental Drug Product Portfolio
  30. 7.5.5 3M Recent Developments
  31. 7.6 Sunstar
  32. 7.6.1 Sunstar Company Information
  33. 7.6.2 Sunstar Business Overview
  34. 7.6.3 Sunstar Dental Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Sunstar Dental Drug Product Portfolio
  36. 7.6.5 Sunstar Recent Developments
  37. 7.7 Colgate-Palmolive
  38. 7.7.1 Colgate-Palmolive Company Information
  39. 7.7.2 Colgate-Palmolive Business Overview
  40. 7.7.3 Colgate-Palmolive Dental Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Colgate-Palmolive Dental Drug Product Portfolio
  42. 7.7.5 Colgate-Palmolive Recent Developments
  43. 7.8 DenMat
  44. 7.8.1 DenMat Company Information
  45. 7.8.2 DenMat Business Overview
  46. 7.8.3 DenMat Dental Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 DenMat Dental Drug Product Portfolio
  48. 7.8.5 DenMat Recent Developments
  49. 7.9 Showa Yakuhin Kako
  50. 7.9.1 Showa Yakuhin Kako Company Information
  51. 7.9.2 Showa Yakuhin Kako Business Overview
  52. 7.9.3 Showa Yakuhin Kako Dental Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Showa Yakuhin Kako Dental Drug Product Portfolio
  54. 7.9.5 Showa Yakuhin Kako Recent Developments
  55. 7.10 Bausch Health
  56. 7.10.1 Bausch Health Company Information
  57. 7.10.2 Bausch Health Business Overview
  58. 7.10.3 Bausch Health Dental Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Bausch Health Dental Drug Product Portfolio
  60. 7.10.5 Bausch Health Recent Developments
  61. 7.11 Septodont
  62. 7.11.1 Septodont Company Information
  63. 7.11.2 Septodont Business Overview
  64. 7.11.3 Septodont Dental Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Septodont Dental Drug Product Portfolio
  66. 7.11.5 Septodont Recent Developments
  67. 7.12 Roche
  68. 7.12.1 Roche Company Information
  69. 7.12.2 Roche Business Overview
  70. 7.12.3 Roche Dental Drug Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Roche Dental Drug Product Portfolio
  72. 7.12.5 Roche Recent Developments
  73. 7.13 PerioChip
  74. 7.13.1 PerioChip Company Information
  75. 7.13.2 PerioChip Business Overview
  76. 7.13.3 PerioChip Dental Drug Revenue and Gross Margin (2021-2026)
  77. 7.13.4 PerioChip Dental Drug Product Portfolio
  78. 7.13.5 PerioChip Recent Developments
  79. 7.14 Hutchison China MediTech
  80. 7.14.1 Hutchison China MediTech Company Information
  81. 7.14.2 Hutchison China MediTech Business Overview
  82. 7.14.3 Hutchison China MediTech Dental Drug Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Hutchison China MediTech Dental Drug Product Portfolio
  84. 7.14.5 Hutchison China MediTech Recent Developments
  85. 7.15 Xiuzheng Pharmaceutical
  86. 7.15.1 Xiuzheng Pharmaceutical Company Information
  87. 7.15.2 Xiuzheng Pharmaceutical Business Overview
  88. 7.15.3 Xiuzheng Pharmaceutical Dental Drug Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Xiuzheng Pharmaceutical Dental Drug Product Portfolio
  90. 7.15.5 Xiuzheng Pharmaceutical Recent Developments
  91. 7.16 Acteon
  92. 7.16.1 Acteon Company Information
  93. 7.16.2 Acteon Business Overview
  94. 7.16.3 Acteon Dental Drug Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Acteon Dental Drug Product Portfolio
  96. 7.16.5 Acteon Recent Developments
  97. 7.17 Xttrium Laboratorie
  98. 7.17.1 Xttrium Laboratorie Company Information
  99. 7.17.2 Xttrium Laboratorie Business Overview
  100. 7.17.3 Xttrium Laboratorie Dental Drug Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Xttrium Laboratorie Dental Drug Product Portfolio
  102. 7.17.5 Xttrium Laboratorie Recent Developments
  103. 7.18 Mediwin Pharmaceuticals
  104. 7.18.1 Mediwin Pharmaceuticals Company Information
  105. 7.18.2 Mediwin Pharmaceuticals Business Overview
  106. 7.18.3 Mediwin Pharmaceuticals Dental Drug Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Mediwin Pharmaceuticals Dental Drug Product Portfolio
  108. 7.18.5 Mediwin Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Dental Drug Revenue (2021-2032)
  2. 8.2 North America Dental Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Dental Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Dental Drug Revenue by Type (2027-2032)
  5. 8.3 North America Dental Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Dental Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Dental Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Dental Drug Revenue by Application (2027-2032)
  9. 8.5 North America Dental Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Dental Drug Revenue by Country
  11. 8.6.1 North America Dental Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Dental Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Dental Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Dental Drug Revenue (2021-2032)
  2. 9.2 Europe Dental Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Dental Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Dental Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Dental Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Dental Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Dental Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Dental Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Dental Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Dental Drug Revenue by Country
  11. 9.6.1 Europe Dental Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Dental Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Dental Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Dental Drug Revenue (2021-2032)
  2. 10.2 China Dental Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Dental Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Dental Drug Revenue by Type (2027-2032)
  5. 10.3 China Dental Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Dental Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Dental Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Dental Drug Revenue by Application (2027-2032)
  9. 10.5 China Dental Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dental Drug Revenue (2021-2032)
  2. 11.2 Asia Dental Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Dental Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Dental Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Dental Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Dental Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Dental Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Dental Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Dental Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Dental Drug Revenue by Country
  11. 11.6.1 Asia Dental Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Dental Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Dental Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dental Drug Revenue (2021-2032)
  2. 12.2 SAMEA Dental Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Dental Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Dental Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Dental Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Dental Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Dental Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Dental Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Dental Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Dental Drug Revenue by Country
  11. 12.6.1 SAMEA Dental Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Dental Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Dental Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research